NCT04520568

High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery

Preventing Deoxygenation With High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery: A Randomized Controlled Trial

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Alexandria University · Academic / Other
• Sex: All
• Age: 30 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

High-flow nasal cannula (HFNC) is a device that delivers10 to 70 L min-1 of heated, humidified 100% oxygen via nasal route. It provides positive airway pressure, decreases dyspnea, decreases the work of breathing, and improves comfort

Detailed description

Beneficial effects of the HFNC system have been assessed based on 3 physiologic conditions: decreased dead space, a high concentration of inspiratory oxygen, and positive pressure in the oro-laryngeal cavity.Studies have shown that it improves oxygenation in various perioperative settings such as the apneic patients, patients with respiratory failure , and patients undergoing bronchoscopy

Conditions

• Chronic Obstructive Pulmonary Disease
• Respiratory Failure

Interventions

Type	Name	Description
COMBINATION_PRODUCT	High flow nasal cannula	using sedation with the HFNC F\&P AIRVOTM 2 to maintain oxygenation
COMBINATION_PRODUCT	CONTROL	using general anaesthesia with one lung ventilation (OLV) technique

Timeline

• Start date: 2020-08-01
• Primary completion: 2020-11-10
• Completion: 2020-12-01
• First posted: 2020-08-20
• Last updated: 2020-08-20

Locations

1 site across 1 country: Egypt